In vivo Identification and Specificity assessment of mRNA markers of hypoxia in human and mouse tumors

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Busk, Morten ^a   Toustrup, Kasper ^a   Sørensen, Brita S ^a   Alsner, Jan ^a   Horsman, Michael R ^a   Jakobsen, Steen ^a   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; LIPOXYGENASE; MESSENGER RNA; CARBONATE DEHYDRATASE; DIAGNOSTIC AGENT; FLUOROAZOMYCIN ARABINOSIDE; NITROIMIDAZOLE DERIVATIVE; PROTEIN LYSINE 6 OXIDASE; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC MARKER; HUMAN; HUMAN CELL; HYPOXIA; IN VIVO STUDY; MOUSE; NONHUMAN; SQUAMOUS CELL CARCINOMA; TISSUE OXYGENATION; TUMOR HYPOXIA; ANIMAL; ANOXIA; C3H MOUSE; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MOUSE STRAIN; NUDE MOUSE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCINTISCANNING; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANOXIA; CARBONIC ANHYDRASES; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MICE; MICE, INBRED C3H; MICE, INBRED STRAINS; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NITROIMIDAZOLES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN-LYSINE 6-OXIDASE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 79651475800     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-63     Document Type: Article

References (42)

1. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 2004, 14:198-206. 10.1016/j.semradonc.2004.04.008, 15254862.
2. Vaupel P, Mayer A, Hockel M. Tumor hypoxia and malignant progression. Methods Enzymol 2004, 381:335-54. full_text, 15063685.
3. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996, 41:31-9.
4. Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005, 77:18-24. 10.1016/j.radonc.2005.06.038, 16098619.
5. Jenkins WT, Evans SM, Koch CJ. Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode. Int J Radiat Oncol Biol Phys 2000, 46:1005-17. 10.1016/S0360-3016(99)00342-9, 10705024.
6. Khalil AA, Horsman MR, Overgaard J. The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation. Acta Oncol 1995, 34:297-300. 10.3109/02841869509093978, 7779412.
7. Padhani AR, Krohn KA, Lewis JS, Alber M. Imaging oxygenation of human tumours. Eur Radiol 2007, 17:861-72. 10.1007/s00330-006-0431-y, 1820761, 17043737.
8. Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007, 407:cm8.
9. Hoogsteen IJ, Marres HA, Bussink J, van der Kogel AJ, Kaanders JH. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review. Head Neck 2007, 29:591-604. 10.1002/hed.20543, 17252597.
10. Mayer A, Hockel M, Vaupel P. Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking?. Strahlenther Onkol 2006, 182:501-10. 10.1007/s00066-006-1525-9, 16944371.
11. Williams KJ, Parker CA, Stratford IJ. Exogenous and endogenous markers of tumour oxygenation status: definitive markers of tumour hypoxia?. Adv Exp Med Biol 2005, 566:285-94. full_text, 16594164.
12. Busk M, Horsman MR, Jakobsen S, Hansen KV, Bussink J, van der KA, et al. Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?. Radiother Oncol 2009, 92:429-36. 10.1016/j.radonc.2009.08.026, 19729214.
13. Busk M, Munk OL, Jakobsen S, Wang T, Skals M, Steiniche T, Horsman MR, Overgaard J. Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET. Acta Oncol 2010, 49:922-33. 10.3109/0284186X.2010.503970, 20831479.
14. Sorensen BS, Toustrup K, Horsman MR, Overgaard J, Alsner J. Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro. Acta Oncol 2010, 49(7):895-905. 10.3109/02841861003614343, 20429727.
15. Estes SD, Stoler DL, Anderson GR. Normal fibroblasts induce the C/EBP beta and ATF-4 bZIP transcription factors in response to anoxia. Exp Cell Res 1995, 220:47-54. 10.1006/excr.1995.1290, 7664842.
16. Vordermark D, Kaffer A, Riedl S, Katzer A, Flentje M. Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. Int J Radiat Oncol Biol Phys 2005, 61:1197-207. 10.1016/j.ijrobp.2004.11.031, 15752902.
17. Boado RJ, Pardridge WM. Glucose deprivation and hypoxia increase the expression of the GLUT1 glucose transporter via a specific mRNA cis-acting regulatory element. J Neurochem 2002, 80:552-4. 10.1046/j.0022-3042.2001.00756.x, 11906001.
18. Sobhanifar S, quino-Parsons C, Stanbridge EJ, Olive P. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors. Cancer Res 2005, 65:7259-66. 10.1158/0008-5472.CAN-04-4480, 16103077.
19. Sorensen BS, Hao J, Overgaard J, Vorum H, Honore B, Alsner J, et al. Influence of oxygen concentration and pH on expression of hypoxia induced genes. Radiother Oncol 2005, 76:187-93. 10.1016/j.radonc.2005.06.037, 16098620.
20. Sorensen BS, Alsner J, Overgaard J, Horsman MR. Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH. Radiother Oncol 2007, 83:362-6. 10.1016/j.radonc.2007.04.028, 17512623.
21. Tanaka H, Yamamoto M, Hashimoto N, Miyakoshi M, Tamakawa S, Yoshie M, et al. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Cancer Res 2006, 66:11263-70. 10.1158/0008-5472.CAN-06-1699, 17145871.
22. Wiesener MS, Munchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, et al. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res 2001, 61:5215-22.
23. Bussink J, Kaanders JH, van der Kogel AJ. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 2003, 67:3-15. 10.1016/S0167-8140(03)00011-2, 12758235.
24. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000, 60:7075-83.
25. Ziemer LS, Koch CJ, Maity A, Magarelli DP, Horan AM, Evans SM. Hypoxia and VEGF mRNA expression in human tumors. Neoplasia 2001, 3:500-8. 10.1038/sj.neo.7900195, 1506560, 11774032.
26. Busk M, Horsman MR, Jakobsen S, Keiding S, van der Kogel AJ, Bussink J, et al. Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy. Int J Radiat Oncol Biol Phys 2008, 70:1202-12. 10.1016/j.ijrobp.2007.11.034, 18313528.
27. Busk M, Horsman MR, Jakobsen S, Bussink J, van der KA, Overgaard J. Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage. Eur J Nucl Med Mol Imaging 2008, 35:2294-303. 10.1007/s00259-008-0888-9, 18682937.
28. Rasey JS, Nelson NJ, Chin L, Evans ML, Grunbaum Z. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. Radiat Res 1990, 122:301-8. 10.2307/3577760, 2356284.
29. Thorwarth D, Eschmann SM, Paulsen F, Alber M. A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia. Phys Med Biol 2005, 50:2209-24. 10.1088/0031-9155/50/10/002, 15876662.
30. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 2006, 440:1222-6. 10.1038/nature04695, 16642001.
31. Wertheimer E, Sasson S, Cerasi E, Ben-Neriah Y. The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein family of stress-inducible proteins. Proc Natl Acad Sci USA 1991, 88:2525-9. 10.1073/pnas.88.6.2525, 51265, 1706526.
32. Yun H, Lee M, Kim SS, Ha J. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. J Biol Chem 2005, 280:9963-72. 10.1074/jbc.M412994200, 15640157.
33. Bruckner BA, Ammini CV, Otal MP, Raizada MK, Stacpoole PW. Regulation of brain glucose transporters by glucose and oxygen deprivation. Metabolism 1999, 48:422-31. 10.1016/S0026-0495(99)90098-7, 10206432.
34. Graven KK, Yu Q, Pan D, Roncarati JS, Farber HW. Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochim Biophys Acta 1999, 1447:208-18.
35. Seagroves TN, Ryan HE, Lu H, Wouters BG, Knapp M, Thibault P, et al. Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol Cell Biol 2001, 21:3436-44. 10.1128/MCB.21.10.3436-3444.2001, 100265, 11313469.
36. Ishioka S, Ezaka Y, Umemura K, Hayashi T, Endo T, Saito T. Proteomic analysis of mechanisms of hypoxia-induced apoptosis in trophoblastic cells. Int J Med Sci 2007, 4:36-44.
37. Dibbens JA, Miller DL, Damert A, Risau W, Vadas MA, Goodall GJ. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol Biol Cell 1999, 10:907-19. 25213, 10198046.
38. Zhong H, Simons JW. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28 S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Commun 1999, 259:523-6. 10.1006/bbrc.1999.0815, 10364451.
39. Said HM, Hagemann C, Stojic J, Schoemig B, Vince GH, Flentje M, et al. GAPDH is not regulated in human glioblastoma under hypoxic conditions. BMC Mol Biol 2007, 8:55. 10.1186/1471-2199-8-55, 1919389, 17597534.
40. Said HM, Polat B, Hagemann C, Anacker J, Flentje M, Vordermark D. Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in vitro. BMC Res Notes 2009, 2:8. 10.1186/1756-0500-2-8, 2646737, 19144146.
41. Acker T, Fandrey J, Acker H. The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases. Cardiovasc Res 2006, 71:195-207. 10.1016/j.cardiores.2006.04.008, 16740253.
42. Kurosh A, Lewis CE, Raida M, Sowter H, Hai T, Harris AL. Anoxic induction of ATF-4 through HIF-1-independent pathways of protein stabilization in human cancer cells. Neoplasia 2004, 103:1876-1882.